Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection

Overview

Journal N Am J Med Sci

Specialty General Medicine

Date 2013 Aug 8

PMID 23923106

Citations 9

Authors

Zeid Karadsheh

Sachin Sule

Affiliations

Soon will be listed here.

Abstract

Clostridium difficile infection (CDI) is currently a leading cause of antibiotic and health care-related diarrhea. The incidence and the severity of CDI-related diarrhea have increased dramatically in the USA and Europe in the past few decades. The emergence of multidrug-resistant hypervirulent strains of C. difficile has led to an increase in mortality. Fecal microbiota transplantation (FMT) (also known as fecal bacteriotherapy) has been utilized sporadically since the 1950s; and currently, the interest in using FMT has grown again in the past few years for the treatment of CDI and other chronic gastrointestinal diseases. FMT has shown to be effective, cheap, and has very few side effects. It is believed to manipulate and restore the gut microbiota, and therefore enhances the growth of "healthy" bacteria that break the cycle of recurrent CDI. This article focus on the recent case reports on FMT, and general approach to patients undergoing this therapy. Data were obtained through a literature search via PubMed and Google.

Citing Articles

Current and Ongoing Developments in Targeting Infection and Recurrence.

Cun W, Keller P, Pyne S Microorganisms. 2024; 12(6).

PMID: 38930588 PMC: 11205563. DOI: 10.3390/microorganisms12061206.

Fast and near-optimal monitoring for healthcare acquired infection outbreaks.

Adhikari B, Lewis B, Vullikanti A, Jimenez J, Prakash B PLoS Comput Biol. 2019; 15(9):e1007284.

PMID: 31525183 PMC: 6762212. DOI: 10.1371/journal.pcbi.1007284.

Fecal microbiota transplantation in recurrent infection: A retrospective single-center chart review.

Kim P, Gadani A, Abdul-Baki H, Mitre R, Mitre M JGH Open. 2019; 3(1):4-9.

PMID: 30834334 PMC: 6386733. DOI: 10.1002/jgh3.12093.

Fecal Transplantation for Treatment of Clostridium Difficile Infection in Elderly and Debilitated Patients.

Friedman-Korn T, Livovsky D, Maharshak N, Cohen N, Paz K, Bar-Gil Shitrit A Dig Dis Sci. 2017; 63(1):198-203.

PMID: 29134299 DOI: 10.1007/s10620-017-4833-2.

Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease.

Roy Chowdhury P, DeMaere M, Chapman T, Worden P, Charles I, Darling A BMC Microbiol. 2016; 16:41.

PMID: 26971047 PMC: 4789261. DOI: 10.1186/s12866-016-0653-3.

References

Rodemann J, Dubberke E, Reske K, Seo D, Stone C . Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5(3):339-44. DOI: 10.1016/j.cgh.2006.12.027. View

Bignardi G . Risk factors for Clostridium difficile infection. J Hosp Infect. 1998; 40(1):1-15. DOI: 10.1016/s0195-6701(98)90019-6. View

Brandt L, Borody T, Campbell J . Endoscopic fecal microbiota transplantation: "first-line" treatment for severe clostridium difficile infection?. J Clin Gastroenterol. 2011; 45(8):655-7. DOI: 10.1097/MCG.0b013e3182257d4f. View

Louie T, Miller M, Mullane K, Weiss K, Lentnek A, Golan Y . Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011; 364(5):422-31. DOI: 10.1056/NEJMoa0910812. View

Reid G, Younes J, van der Mei H, Gloor G, Knight R, Busscher H . Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol. 2010; 9(1):27-38. DOI: 10.1038/nrmicro2473. View

Mattila E, Anttila V, Broas M, Marttila H, Poukka P, Kuusisto K . A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis. 2008; 40(9):702-8. DOI: 10.1080/00365540801964960. View

Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh S . Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052):105-8. PMC: 3368382. DOI: 10.1126/science.1208344. View

McFarland L, Surawicz C, Greenberg R, FEKETY R, Elmer G, Moyer K . A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994; 271(24):1913-8. View

Russell G, Kaplan J, Ferraro M, Michelow I . Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics. 2010; 126(1):e239-42. DOI: 10.1542/peds.2009-3363. View

10.

Imhoff A, Karpa K . Is there a future for probiotics in preventing Clostridium difficile-associated disease and treatment of recurrent episodes?. Nutr Clin Pract. 2009; 24(1):15-32. DOI: 10.1177/0884533608329232. View

11.

Kelly C, Lamont J . Clostridium difficile--more difficult than ever. N Engl J Med. 2008; 359(18):1932-40. DOI: 10.1056/NEJMra0707500. View

12.

Surawicz C . Treatment of recurrent Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol. 2005; 1(1):32-8. DOI: 10.1038/ncpgasthep0018. View

13.

Arango J, Restrepo A, Schneider D, Callander N, Ochoa-Bayona J, Restrepo M . Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 2006; 37(5):517-21. DOI: 10.1038/sj.bmt.1705269. View

14.

Mariat D, Firmesse O, Levenez F, Guimaraes V, Sokol H, Dore J . The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009; 9:123. PMC: 2702274. DOI: 10.1186/1471-2180-9-123. View

15.

Spor A, Koren O, Ley R . Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011; 9(4):279-90. DOI: 10.1038/nrmicro2540. View

16.

Khoruts A, Dicksved J, Jansson J, Sadowsky M . Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2010; 44(5):354-60. DOI: 10.1097/MCG.0b013e3181c87e02. View

17.

Gerding D, Johnson S . Management of Clostridium difficile infection: thinking inside and outside the box. Clin Infect Dis. 2010; 51(11):1306-13. DOI: 10.1086/657116. View

18.

Yoon S, Brandt L . Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol. 2010; 44(8):562-6. DOI: 10.1097/MCG.0b013e3181dac035. View

19.

Eiseman B, Silen W, BASCOM G, KAUVAR A . Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958; 44(5):854-9. View

20.

Marques T, Wall R, Ross R, Fitzgerald G, Ryan C, Stanton C . Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol. 2010; 21(2):149-56. DOI: 10.1016/j.copbio.2010.03.020. View